A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin AntibodyShinji Abe, Yasuhiko Nishioka, Yuki Morita et al.|The Journal of Immunology|2013Cited by 91
Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi‐specific monoclonal antibody MsMab‐1Xing Liu, Michiaki Takagi, Yukinari Kato et al.|Cancer Medicine|2013Cited by 52
Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of boneMika K. Kaneko, Yukinari Kato, Hiroharu Oki et al.|Cancer Science|2014Cited by 44
Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of PodoplaninHiroharu Oki, Yukinari Kato, Mika K. Kaneko et al.|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|2015Cited by 36
Multi-Specific Monoclonal Antibody MsMab-2 Recognizes IDH1-R132L and IDH2-R172M MutationsSatoshi Ogasawara, Yukinari Kato, Mika K. Kaneko et al.|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|2013Cited by 20